WMT

125.11

-0.71%↓

COST

996.16

-0.57%↓

PG

151.49

-0.36%↓

KO

77.6

-0.26%↓

PM

172.78

-1.1%↓

WMT

125.11

-0.71%↓

COST

996.16

-0.57%↓

PG

151.49

-0.36%↓

KO

77.6

-0.26%↓

PM

172.78

-1.1%↓

WMT

125.11

-0.71%↓

COST

996.16

-0.57%↓

PG

151.49

-0.36%↓

KO

77.6

-0.26%↓

PM

172.78

-1.1%↓

WMT

125.11

-0.71%↓

COST

996.16

-0.57%↓

PG

151.49

-0.36%↓

KO

77.6

-0.26%↓

PM

172.78

-1.1%↓

WMT

125.11

-0.71%↓

COST

996.16

-0.57%↓

PG

151.49

-0.36%↓

KO

77.6

-0.26%↓

PM

172.78

-1.1%↓

Search

Afya Ltd (Class A)

Uždarymo kaina

SektoriusVartotojų apsauga

14.23 0.07

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

14.09

Max

14.44

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-5M

176M

Pardavimai

-1.6M

927M

P/E

Sektoriaus vid.

9.108

28.772

Dividendų pajamingumas

4.64

Pelno marža

18.945

EBITDA

-120M

277M

Rekomendacijos

By TipRanks

Rekomendacijos

Neutralu

12 mėnesių prognozė

+23.08% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

4.64%

3.67%

Kitas uždarbis

2026-05-07

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

26M

1.3B

Ankstesnė atidarymo kaina

14.16

Ankstesnė uždarymo kaina

14.23

Naujienos nuotaikos

By Acuity

100%

0%

126 / 131 reitingas Consumer defensive

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Bullish Evidence

Afya Ltd (Class A) Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-03-17 22:42; UTC

Uždarbis

Prudential PLC 2025 Adjusted Operating Profit Rises

2026-03-17 21:40; UTC

Uždarbis

Alimentation Couche-Tard Records Higher Profit, Revenue in 3Q

2026-03-17 23:56; UTC

Rinkos pokalbiai

BHP's Next CEO Likely to Build On Existing Strategic Direction -- Market Talk

2026-03-17 23:46; UTC

Rinkos pokalbiai

Nikkei May Rise After Recent Selloffs -- Market Talk

2026-03-17 23:42; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-03-17 23:42; UTC

Rinkos pokalbiai

RBA's Return to Policy Tightening Will Work -- Market Talk

2026-03-17 23:38; UTC

Rinkos pokalbiai

Gold Edges Lower on Possible Position Adjustments Before FOMC Decision -- Market Talk

2026-03-17 23:24; UTC

Rinkos pokalbiai

Global Energy Roundup: Market Talk

2026-03-17 23:24; UTC

Rinkos pokalbiai

New Woodside CEO Seen as Low-Risk Appointment -- Market Talk

2026-03-17 22:22; UTC

Rinkos pokalbiai

BHP Hands Reins to Growth-Focused Executive -- Market Talk

2026-03-17 22:20; UTC

Uždarbis

Prudential PLC 2025 New Business Profit $2.78B Vs. $2.46B >2378.HK

2026-03-17 22:20; UTC

Uždarbis

Prudential PLC 2025 Adj Operating Profit $3.31B Vs. $3.13B >2378.HK

2026-03-17 22:07; UTC

Uždarbis

Nvidia Says It Is Restarting Production of AI Chips for Sale in China -- WSJ

2026-03-17 22:05; UTC

Uždarbis

ZTO Express (Cayman): Frank Zhen Wei to Resign From Board

2026-03-17 22:04; UTC

Uždarbis

ZTO Express (Cayman): Board Approves Repurchase of Up to $1.5B of Shares Over Next 24 Months >ZTO

2026-03-17 22:03; UTC

Uždarbis

ZTO Express (Cayman) Raises Semiannual Dividend to 39c Vs. 30c >ZTO

2026-03-17 22:01; UTC

Uždarbis

ZTO Express (Cayman) 4Q Adj EPS 47c >ZTO

2026-03-17 22:01; UTC

Uždarbis

ZTO Express (Cayman) 4Q Rev $2.08B >ZTO

2026-03-17 22:01; UTC

Uždarbis

ZTO Express (Cayman) 4Q EPS 47c >ZTO

2026-03-17 21:26; UTC

Uždarbis

Oklo Stock Wavers After Earnings, but the Nuclear Start-Up Has Good News -- Barrons.com

2026-03-17 21:09; UTC

Uždarbis

Couche-Tard: 12 Company-Operated Stores Acquired During 3Q

2026-03-17 21:08; UTC

Uždarbis

Couche-Tard 3Q Consolidated Same-Store Merchandise Revenue Up 2% >ATD.T

2026-03-17 21:08; UTC

Uždarbis

Couche-Tard 3Q Adj EPS 81c >ATD.T

2026-03-17 21:07; UTC

Uždarbis

Couche-Tard 3Q EPS 82c >ATD.T

2026-03-17 21:06; UTC

Uždarbis

Couche-Tard 3Q Rev $21.8B >ATD.T

2026-03-17 21:05; UTC

Uždarbis

Couche-Tard 3Q Adj EPS 81c >ATD.T

2026-03-17 21:05; UTC

Uždarbis

Couche-Tard 3Q Rev $21.8B >ATD.T

2026-03-17 21:05; UTC

Uždarbis

Couche-Tard 3Q EPS 82c >ATD.T

2026-03-17 21:05; UTC

Uždarbis

Couche-Tard 3Q Net $757.2M >ATD.T

2026-03-17 20:50; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Energy & Utilities Roundup: Market Talk

Akcijų palyginimas

Kainos pokytis

Afya Ltd (Class A) Prognozė

Kainos tikslas

By TipRanks

23.08% į viršų

12 mėnesių prognozė

Vidutinis 17.6 USD  23.08%

Aukščiausias 22 USD

Žemiausias 16 USD

Remiantis 5 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Afya Ltd (Class A) kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Neutralu

5 ratings

0

Pirkti

4

Laikyti

1

Parduoti

Techninis įvertinimas

By Trading Central

18.968 / 19.56Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Bullish Evidence

Vidutinės trukmės periodas

Bullish Evidence

Ilgalaikis periodas

Strong Bullish Evidence

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Afya Ltd (Class A)

Afya Limited operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services. Further, it offers iClinic, a practice management software; educational health and medical imaging solutions through an interactive platform; Cliquefarma, a free-to-use website that tracks prescription drugs, cosmetics and personal hygiene product prices; Shosp, a clinical management software; RX PRO, a solution that connects physicians with the pharmaceutical industry; and Glic, a free diabetes care and management app solution for physicians and patients. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.
help-icon Live chat